サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1539367

血液分析装置市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年

Hematology Analyzers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 297 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
血液分析装置市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年
出版日: 2024年08月21日
発行: Persistence Market Research
ページ情報: 英文 297 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界の血液分析装置市場に関する幅広い調査レポートを出版し、原動力、新たな動向、機会、課題など、重要な市場力学の包括的な分析を提供しました。この調査レポートは、市場情勢を詳細に理解し、利害関係者が十分な情報に基づいた意思決定を行えるよう支援します。

主な洞察

  • 血液分析装置の市場規模（2024E）：14億米ドル
  • 予測市場規模（2033F）：22億米ドル
  • 世界市場成長率（CAGR 2024年から2033年まで）：5.4%

血球計数装置市場- レポート範囲：

血液分析装置市場には、血液サンプルの分析に使用され、異常の検出、疾患の診断、患者の健康状態をモニターするための様々な診断装置が含まれます。これらの分析装置は、全血球算定（CBC）、微分血算、凝固検査などの包括的な血液検査を行う臨床検査室において極めて重要です。この市場を牽引しているのは、技術の進歩、精密な診断に対する需要の高まり、病気の早期発見に対する関心の高まりです。

市場促進要因：

血液分析装置の世界市場は、血液疾患の有病率の上昇、高齢化人口の増加、血液検査技術の進歩など、いくつかの重要な要因によって活性化されます。より迅速で正確な検査結果を求めるニーズにより、自動化された高スループット分析装置の需要が拡大しています。血液分析装置への人工知能（AI）と機械学習の統合は診断能力を高め、市場の成長をさらに後押ししています。さらに、ヘルスケアインフラの拡大やポイントオブケア検査の導入拡大も市場拡大に寄与しています。

市場抑制要因：

市場成長の可能性にもかかわらず、血液分析装置市場は、高度な分析装置の高価格や複雑な装置を操作する熟練者の必要性といった課題に直面しています。また、規制上のハードルや厳しい品質基準への準拠の必要性にも直面しています。検査結果の正確性と信頼性の確保は極めて重要であり、この点で問題があれば市場の成長に影響を及ぼす可能性があります。さらに、最新鋭の血液分析装置には高額な初期投資が必要となるため、特に小規模なヘルスケア施設にとっては障壁となる可能性があります。

市場機会：

血液分析装置市場は、技術革新とヘルスケア投資の増加によって大きなビジネスチャンスを迎えています。コンパクトでポータブルな分析装置の市場開拓と次世代シーケンサー技術のイントロダクションが、市場成長の新たな道を開いています。予防ヘルスケアと早期診断の増加は、高度な血液学検査ソリューションの需要を促進しています。戦略的パートナーシップ、ソフトウェア統合の進展、研究開発への投資は、こうした機会を活用し市場での存在感の拡大を目指す企業にとって不可欠です。

本レポートで扱う主な質問

  • 血液分析装置市場の世界の成長を促進する主な要因は何か？
  • 血液分析装置の採用をリードしているアプリケーションと地域はどこか？
  • 技術進歩は血液分析装置市場の競合情勢をどのように変えているか？
  • 血液分析装置市場の主要プレーヤーは誰で、競争力を維持するためにどのような戦略を採用しているのか？
  • 血液分析装置の世界市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 重要成功要因

  • 製品の採用/使用状況分析
  • 製品のUSP/特徴
  • 規制シナリオ
  • 技術評価
  • バリューチェーン分析
  • 最近の製品承認と発売
  • PESTLE分析
  • ポーター分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • ダイナミクス

第6章 COVID-19危機- 影響評価

  • COVID-19と影響分析
    • 製品別
    • モダリティ別
    • エンドユーザー別
    • 地域別
  • 2024年の市場シナリオ

第7章 世界市場規模（数量）分析

  • 市場（数量）分析、2019～2023年
  • 市場（数量）予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第8章 世界市場- 価格分析

  • 製品別の地域別価格分析
  • 価格の内訳
    • メーカーレベルの価格設定
    • ディストリビューターレベルの価格設定
  • 世界平均価格分析ベンチマーク
  • 価格設定の前提

第9章 世界市場の需要（金額および規模）分析

  • 市場（金額）分析、2019～2023年
  • 市場（金額）予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第10章 製品別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額および数量）分析、2019～2023年
  • 市場規模（金額および数量）分析と予測、2024～2033年
    • 3部構成の分析装置
    • 5部構成の分析装置
    • その他
  • 市場の魅力分析

第11章 モダリティ別：世界市場分析別

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • スタンドアロン
    • ポイントオブケア
  • 市場の魅力分析

第12章 エンドユーザー別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 病院
    • 診断センター
    • 外来手術センター
    • 血液銀行
  • 市場の魅力分析

第13章 地域別：世界市場分析

  • イントロダクション
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東およびアフリカ（中東・アフリカ）
  • 市場の魅力分析

第14章 北米市場分析

第15章 ラテンアメリカ市場分析

第16章 欧州市場分析

第17章 南アジア市場分析

第18章 東アジア市場分析

第19章 オセアニア市場分析

第20章 中東・アフリカ市場分析

第21章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第22章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • SYSMAX CORPORATION
    • Abbott Laboratories
    • Beckman Coulter Inc
    • Siemens AG
    • Boule Diagnostics AB.
    • Nihon Kohden Corporation
    • Mindray
    • HORIBA Ltd.
    • Diatron
    • Cellavision
    • Edan Instrumnets, Inc
    • SAMSUNG
    • Biosystems SA
    • F. Hoffmann-La Roche Ltd.
    • Shenzhen Dymind Biotechnology Co. Ltd.
    • PZ CORMAY SA
    • PixCell
    • Shenzhen Landwind Insdustry Co. Ltd.
    • Rayto Life and Analytical Sciences Co. Ltd
    • Shenzen Prokan Electronics Inc.

第23章 使用される前提条件と頭字語

第24章 調査手法

目次
Product Code: PMRREP16510

Persistence Market Research has recently published an extensive report on the global Hematology Analyzers Market, offering a comprehensive analysis of critical market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report provides a detailed understanding of the market landscape, assisting stakeholders in making informed decisions.

Key Insights:

  • Hematology Analyzers Market Size (2024E): USD 1.4 Bn
  • Projected Market Value (2033F): USD 2.2 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.4%

Hematology Analyzers Market - Report Scope:

The Hematology Analyzers Market includes a variety of diagnostic devices used for analyzing blood samples to detect abnormalities, diagnose diseases, and monitor patient health. These analyzers are crucial in clinical laboratories for comprehensive blood tests, including complete blood counts (CBC), differential blood counts, and coagulation studies. The market is driven by advancements in technology, increasing demand for precise diagnostics, and a growing focus on early disease detection.

Market Growth Drivers:

The global Hematology Analyzers Market is fueled by several key factors, including the rising prevalence of blood disorders, an increasing aging population, and advancements in hematology technology. The demand for automated and high-throughput analyzers is growing, driven by the need for faster and more accurate test results. The integration of artificial intelligence (AI) and machine learning into hematology analyzers is enhancing diagnostic capabilities, further boosting market growth. Additionally, the expansion of healthcare infrastructure and the rising adoption of point-of-care testing are contributing to the market's expansion.

Market Restraints:

Despite its growth potential, the Hematology Analyzers Market faces challenges such as high costs of advanced analyzers and the need for skilled personnel to operate complex equipment. The market also encounters regulatory hurdles and the need for compliance with stringent quality standards. Ensuring the accuracy and reliability of test results is critical, and any issues in this regard could impact market growth. Additionally, the high initial investment required for state-of-the-art hematology analyzers may pose a barrier, especially for smaller healthcare facilities.

Market Opportunities:

The Hematology Analyzers Market presents significant opportunities driven by technological innovations and increasing healthcare investments. The development of compact, portable analyzers and the introduction of next-generation sequencing technologies are opening new avenues for market growth. The rise in preventive healthcare and early diagnosis is driving demand for advanced hematology testing solutions. Strategic partnerships, advancements in software integration, and investments in research and development are essential for companies aiming to leverage these opportunities and expand their market presence.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Hematology Analyzers Market globally?
  • Which applications and regions are leading the adoption of hematology analyzers?
  • How are technological advancements reshaping the competitive landscape of the Hematology Analyzers Market?
  • Who are the key players in the Hematology Analyzers Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Hematology Analyzers Market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Hematology Analyzers Market, such as Abbott Laboratories, Sysmex Corporation, and Beckman Coulter, are focusing on innovation, technological advancements, and strategic partnerships to maintain a competitive edge. These companies are investing in research and development to enhance the capabilities of hematology analyzers, improve diagnostic accuracy, and streamline operations. Collaborations with healthcare providers, technology firms, and research institutions are vital for expanding market reach and driving the adoption of advanced hematology solutions. Emphasizing user-friendly designs, robust performance, and regulatory compliance are key strategies for sustaining leadership in the rapidly evolving Hematology Analyzers Market.

Key Companies Profiled:

  • SYSMAX CORPORATION
  • Abbott Laboratories
  • Beckman Coulter Inc
  • Siemens AG
  • Boule Diagnostics AB.
  • Nihon Kohden Corporation
  • Mindray
  • HORIBA Ltd.
  • Diatron
  • Cellavision
  • Edan Instrumnets, Inc
  • SAMSUNG
  • Biosystems SA
  • F. Hoffmann-La Roche Ltd.
  • Shenzhen Dymind Biotechnology Co. Ltd.
  • PZ CORMAY SA
  • PixCell
  • Shenzhen Landwind Insdustry Co. Ltd.
  • Rayto Life and Analytical Sciences Co. Ltd
  • Shenzen Prokan Electronics Inc.

Key Segments Covered in Hematology Analyzers Industry Research

Product:

  • 3-Part
  • 5-Part

Modality:

  • Standalone
  • Point of Care

End User:

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Blood Banks

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Regulatory Scenario
  • 4.4. Technology Assessment
  • 4.5. Value Chain Analysis
  • 4.6. Recent Product Approval and Launches
  • 4.7. PESTLE Analysis
  • 4.8. Porter Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Haematology Diagnostics Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Growth of the Top Companies
    • 5.2.2. Technological Advancements
    • 5.2.3. Rising Prevalence of Blood Related Disorders
    • 5.2.4. Cost of the Products
    • 5.2.5. Product and Stock Availability
    • 5.2.6. Increasing Cases of Non-Communicable Diseases and Thalassemia
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Modality
    • 6.1.3. BY End User
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Volume (in Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Volume (in Units) Analysis, 2019-2023
  • 7.2. Current and Future Volume (in Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
    • 10.3.1. 3-Part Analyzers
    • 10.3.2. 5-Part Analyzers
    • 10.3.3. Others
  • 10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Modality

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis By Modality, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Modality, 2024-2033
    • 11.3.1. Standalone
    • 11.3.2. Point of Care
  • 11.4. Market Attractiveness Analysis By Modality

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Diagnostic Centers
    • 12.3.3. Ambulatory Surgical Centers
    • 12.3.4. Blood Banks
  • 12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Modality
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Modality
    • 14.4.4. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. U.S. Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Product
        • 14.5.1.2.2. By Modality
        • 14.5.1.2.3. By End User
    • 14.5.2. Canada Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Product
        • 14.5.2.2.2. By Modality
        • 14.5.2.2.3. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Modality
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Modality
    • 15.4.4. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. Brazil Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Product
        • 15.5.1.2.2. By Modality
        • 15.5.1.2.3. By End User
    • 15.5.2. Mexico Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Product
        • 15.5.2.2.2. By Modality
        • 15.5.2.2.3. By End User
    • 15.5.3. Argentina Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Product
        • 15.5.3.2.2. By Modality
        • 15.5.3.2.3. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. France
      • 16.3.1.3. Italy
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. Russia
      • 16.3.1.7. BENELUX
      • 16.3.1.8. Nordic Countries
      • 16.3.1.9. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Modality
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Modality
    • 16.4.4. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. Germany Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Product
        • 16.5.1.2.2. By Modality
        • 16.5.1.2.3. By End User
    • 16.5.2. France Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Product
        • 16.5.2.2.2. By Modality
        • 16.5.2.2.3. By End User
    • 16.5.3. Italy Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Product
        • 16.5.3.2.2. By Modality
        • 16.5.3.2.3. By End User
    • 16.5.4. U.K. Market Analysis
      • 16.5.4.1. Introduction
      • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.4.2.1. By Product
        • 16.5.4.2.2. By Modality
        • 16.5.4.2.3. By End User
    • 16.5.5. Spain Market Analysis
      • 16.5.5.1. Introduction
      • 16.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.5.2.1. By Product
        • 16.5.5.2.2. By Modality
        • 16.5.5.2.3. By End User
    • 16.5.6. Russia Market Analysis
      • 16.5.6.1. Introduction
      • 16.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.6.2.1. By Product
        • 16.5.6.2.2. By Modality
        • 16.5.6.2.3. By End User
    • 16.5.7. Nordic Countries Market Analysis
      • 16.5.7.1. Introduction
      • 16.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.7.2.1. By Product
        • 16.5.7.2.2. By Modality
        • 16.5.7.2.3. By End User
    • 16.5.8. BENELUX Market Analysis
      • 16.5.8.1. Introduction
      • 16.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.8.2.1. By Product
        • 16.5.8.2.2. By Modality
        • 16.5.8.2.3. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Modality
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Modality
    • 17.4.4. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. India Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Product
        • 17.5.1.2.2. By Modality
        • 17.5.1.2.3. By End User
    • 17.5.2. Thailand Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Product
        • 17.5.2.2.2. By Modality
        • 17.5.2.2.3. By End User
    • 17.5.3. Indonesia Market Analysis
      • 17.5.3.1. Introduction
      • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.3.2.1. By Product
        • 17.5.3.2.2. By Modality
        • 17.5.3.2.3. By End User
    • 17.5.4. Malaysia Market Analysis
      • 17.5.4.1. Introduction
      • 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.4.2.1. By Product
        • 17.5.4.2.2. By Modality
        • 17.5.4.2.3. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product
    • 18.3.3. By Modality
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Modality
    • 18.4.4. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. China Market Analysis
      • 18.5.1.1. Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Product
        • 18.5.1.2.2. By Modality
        • 18.5.1.2.3. By End User
    • 18.5.2. Japan Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Product
        • 18.5.2.2.2. By Modality
        • 18.5.2.2.3. By End User
    • 18.5.3. South Korea Market Analysis
      • 18.5.3.1. Introduction
      • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.3.2.1. By Product
        • 18.5.3.2.2. By Modality
        • 18.5.3.2.3. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Modality
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Modality
    • 19.4.4. By End User
  • 19.5. Country Level Analysis & Forecast
    • 19.5.1. Australia Market Analysis
      • 19.5.1.1. Introduction
      • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.1.2.1. By Product
        • 19.5.1.2.2. By Modality
        • 19.5.1.2.3. By End User
    • 19.5.2. New Zealand Market Analysis
      • 19.5.2.1. Introduction
      • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.2.2.1. By Product
        • 19.5.2.2.2. By Modality
        • 19.5.2.2.3. By End User
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. Northern Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Modality
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Modality
    • 20.4.4. By End User
  • 20.5. Country Level Analysis & Forecast
    • 20.5.1. GCC Countries Market Analysis
      • 20.5.1.1. Introduction
      • 20.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.5.1.2.1. By Product
        • 20.5.1.2.2. By Modality
        • 20.5.1.2.3. By End User
    • 20.5.2. Turkiye Market Analysis
      • 20.5.2.1. Introduction
      • 20.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.5.2.2.1. By Product
        • 20.5.2.2.2. By Modality
        • 20.5.2.2.3. By End User
    • 20.5.3. Northern Africa Market Analysis
      • 20.5.3.1. Introduction
      • 20.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.5.3.2.1. By Product
        • 20.5.3.2.2. By Modality
        • 20.5.3.2.3. By End User
    • 20.5.4. South Africa Market Analysis
      • 20.5.4.1. Introduction
      • 20.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.5.4.2.1. By Product
        • 20.5.4.2.2. By Modality
        • 20.5.4.2.3. By End User
  • 20.6. Market Trends
  • 20.7. Key Market Participants - Intensity Mapping
  • 20.8. Drivers and Restraints - Impact Analysis

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. SYSMAX CORPORATION
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Key Financials
      • 22.3.1.4. SWOT Analysis
      • 22.3.1.5. Sales Footprint
      • 22.3.1.6. Strategy Overview
        • 22.3.1.6.1. Marketing Strategy
        • 22.3.1.6.2. Product Strategy
        • 22.3.1.6.3. Channel Strategy
    • 22.3.2. Abbott Laboratories
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Key Financials
      • 22.3.2.4. SWOT Analysis
      • 22.3.2.5. Sales Footprint
      • 22.3.2.6. Strategy Overview
        • 22.3.2.6.1. Marketing Strategy
        • 22.3.2.6.2. Product Strategy
        • 22.3.2.6.3. Channel Strategy
    • 22.3.3. Beckman Coulter Inc
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Key Financials
      • 22.3.3.4. SWOT Analysis
      • 22.3.3.5. Sales Footprint
      • 22.3.3.6. Strategy Overview
        • 22.3.3.6.1. Marketing Strategy
        • 22.3.3.6.2. Product Strategy
        • 22.3.3.6.3. Channel Strategy
    • 22.3.4. Siemens AG
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Key Financials
      • 22.3.4.4. SWOT Analysis
      • 22.3.4.5. Sales Footprint
      • 22.3.4.6. Strategy Overview
        • 22.3.4.6.1. Marketing Strategy
        • 22.3.4.6.2. Product Strategy
        • 22.3.4.6.3. Channel Strategy
    • 22.3.5. Boule Diagnostics AB.
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Key Financials
      • 22.3.5.4. SWOT Analysis
      • 22.3.5.5. Sales Footprint
      • 22.3.5.6. Strategy Overview
        • 22.3.5.6.1. Marketing Strategy
        • 22.3.5.6.2. Product Strategy
        • 22.3.5.6.3. Channel Strategy
    • 22.3.6. Nihon Kohden Corporation
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Key Financials
      • 22.3.6.4. SWOT Analysis
      • 22.3.6.5. Sales Footprint
      • 22.3.6.6. Strategy Overview
        • 22.3.6.6.1. Marketing Strategy
        • 22.3.6.6.2. Product Strategy
        • 22.3.6.6.3. Channel Strategy
    • 22.3.7. Mindray
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Key Financials
      • 22.3.7.4. SWOT Analysis
      • 22.3.7.5. Sales Footprint
      • 22.3.7.6. Strategy Overview
        • 22.3.7.6.1. Marketing Strategy
        • 22.3.7.6.2. Product Strategy
        • 22.3.7.6.3. Channel Strategy
    • 22.3.8. HORIBA Ltd.
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Key Financials
      • 22.3.8.4. SWOT Analysis
      • 22.3.8.5. Sales Footprint
      • 22.3.8.6. Strategy Overview
        • 22.3.8.6.1. Marketing Strategy
        • 22.3.8.6.2. Product Strategy
        • 22.3.8.6.3. Channel Strategy
    • 22.3.9. Diatron
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Key Financials
      • 22.3.9.4. SWOT Analysis
      • 22.3.9.5. Sales Footprint
      • 22.3.9.6. Strategy Overview
        • 22.3.9.6.1. Marketing Strategy
        • 22.3.9.6.2. Product Strategy
        • 22.3.9.6.3. Channel Strategy
    • 22.3.10. Cellavision
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Key Financials
      • 22.3.10.4. SWOT Analysis
      • 22.3.10.5. Sales Footprint
      • 22.3.10.6. Strategy Overview
        • 22.3.10.6.1. Marketing Strategy
        • 22.3.10.6.2. Product Strategy
        • 22.3.10.6.3. Channel Strategy
    • 22.3.11. Edan Instrumnets, Inc
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Key Financials
      • 22.3.11.4. SWOT Analysis
      • 22.3.11.5. Sales Footprint
      • 22.3.11.6. Strategy Overview
        • 22.3.11.6.1. Marketing Strategy
        • 22.3.11.6.2. Product Strategy
        • 22.3.11.6.3. Channel Strategy
    • 22.3.12. SAMSUNG
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Key Financials
      • 22.3.12.4. SWOT Analysis
      • 22.3.12.5. Sales Footprint
      • 22.3.12.6. Strategy Overview
        • 22.3.12.6.1. Marketing Strategy
        • 22.3.12.6.2. Product Strategy
        • 22.3.12.6.3. Channel Strategy
    • 22.3.13. Biosystems SA
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Key Financials
      • 22.3.13.4. SWOT Analysis
      • 22.3.13.5. Sales Footprint
      • 22.3.13.6. Strategy Overview
        • 22.3.13.6.1. Marketing Strategy
        • 22.3.13.6.2. Product Strategy
        • 22.3.13.6.3. Channel Strategy
    • 22.3.14. F. Hoffmann-La Roche Ltd.
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Key Financials
      • 22.3.14.4. SWOT Analysis
      • 22.3.14.5. Sales Footprint
      • 22.3.14.6. Strategy Overview
        • 22.3.14.6.1. Marketing Strategy
        • 22.3.14.6.2. Product Strategy
        • 22.3.14.6.3. Channel Strategy
    • 22.3.15. Shenzhen Dymind Biotechnology Co. Ltd.
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Key Financials
      • 22.3.15.4. SWOT Analysis
      • 22.3.15.5. Sales Footprint
      • 22.3.15.6. Strategy Overview
        • 22.3.15.6.1. Marketing Strategy
        • 22.3.15.6.2. Product Strategy
        • 22.3.15.6.3. Channel Strategy
    • 22.3.16. PZ CORMAY SA
      • 22.3.16.1. Overview
      • 22.3.16.2. Product Portfolio
      • 22.3.16.3. Key Financials
      • 22.3.16.4. SWOT Analysis
      • 22.3.16.5. Sales Footprint
      • 22.3.16.6. Strategy Overview
        • 22.3.16.6.1. Marketing Strategy
        • 22.3.16.6.2. Product Strategy
        • 22.3.16.6.3. Channel Strategy
    • 22.3.17. PixCell
      • 22.3.17.1. Overview
      • 22.3.17.2. Product Portfolio
      • 22.3.17.3. Key Financials
      • 22.3.17.4. SWOT Analysis
      • 22.3.17.5. Sales Footprint
      • 22.3.17.6. Strategy Overview
        • 22.3.17.6.1. Marketing Strategy
        • 22.3.17.6.2. Product Strategy
        • 22.3.17.6.3. Channel Strategy
    • 22.3.18. Shenzhen Landwind Insdustry Co. Ltd.
      • 22.3.18.1. Overview
      • 22.3.18.2. Product Portfolio
      • 22.3.18.3. Key Financials
      • 22.3.18.4. SWOT Analysis
      • 22.3.18.5. Sales Footprint
      • 22.3.18.6. Strategy Overview
        • 22.3.18.6.1. Marketing Strategy
        • 22.3.18.6.2. Product Strategy
        • 22.3.18.6.3. Channel Strategy
    • 22.3.19. Rayto Life and Analytical Sciences Co. Ltd
      • 22.3.19.1. Overview
      • 22.3.19.2. Product Portfolio
      • 22.3.19.3. Key Financials
      • 22.3.19.4. SWOT Analysis
      • 22.3.19.5. Sales Footprint
      • 22.3.19.6. Strategy Overview
        • 22.3.19.6.1. Marketing Strategy
        • 22.3.19.6.2. Product Strategy
        • 22.3.19.6.3. Channel Strategy
    • 22.3.20. Shenzen Prokan Electronics Inc.
      • 22.3.20.1. Overview
      • 22.3.20.2. Product Portfolio
      • 22.3.20.3. Key Financials
      • 22.3.20.4. SWOT Analysis
      • 22.3.20.5. Sales Footprint
      • 22.3.20.6. Strategy Overview
        • 22.3.20.6.1. Marketing Strategy
        • 22.3.20.6.2. Product Strategy
        • 22.3.20.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology